CO2017011722A2 - Formulaciones que contienen diacereína y métodos que las utilizan para disminuir el nivel del ácido úrico en sangre - Google Patents
Formulaciones que contienen diacereína y métodos que las utilizan para disminuir el nivel del ácido úrico en sangreInfo
- Publication number
- CO2017011722A2 CO2017011722A2 CONC2017/0011722A CO2017011722A CO2017011722A2 CO 2017011722 A2 CO2017011722 A2 CO 2017011722A2 CO 2017011722 A CO2017011722 A CO 2017011722A CO 2017011722 A2 CO2017011722 A2 CO 2017011722A2
- Authority
- CO
- Colombia
- Prior art keywords
- blood
- level
- uric acid
- methods
- formulations containing
- Prior art date
Links
- TYNLGDBUJLVSMA-UHFFFAOYSA-N 4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic acid Chemical compound O=C1C2=CC(C(O)=O)=CC(OC(C)=O)=C2C(=O)C2=C1C=CC=C2OC(=O)C TYNLGDBUJLVSMA-UHFFFAOYSA-N 0.000 title abstract 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title abstract 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title abstract 2
- 210000004369 blood Anatomy 0.000 title abstract 2
- 229960004590 diacerein Drugs 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 229940116269 uric acid Drugs 0.000 title abstract 2
- 238000013270 controlled release Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2015/026678 WO2016171656A1 (fr) | 2015-04-20 | 2015-04-20 | Préparations à base de diacéréine et procédés de réduction des taux d'acide urique sanguins grâce à l'utilisation de cette dernière |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2017011722A2 true CO2017011722A2 (es) | 2018-04-19 |
Family
ID=57143313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2017/0011722A CO2017011722A2 (es) | 2015-04-20 | 2017-11-17 | Formulaciones que contienen diacereína y métodos que las utilizan para disminuir el nivel del ácido úrico en sangre |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3285754A4 (fr) |
| JP (1) | JP2018513203A (fr) |
| KR (1) | KR20180013880A (fr) |
| CN (1) | CN107708681A (fr) |
| AU (1) | AU2015392441A1 (fr) |
| BR (1) | BR112017022509A2 (fr) |
| CA (1) | CA2983394A1 (fr) |
| CO (1) | CO2017011722A2 (fr) |
| IL (1) | IL255073A0 (fr) |
| MX (1) | MX2017013489A (fr) |
| RU (1) | RU2690372C2 (fr) |
| WO (1) | WO2016171656A1 (fr) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06316517A (ja) * | 1993-02-22 | 1994-11-15 | Grelan Pharmaceut Co Ltd | 放出制御製剤 |
| KR20070058540A (ko) * | 2004-10-01 | 2007-06-08 | 니폰 조키 세야쿠 가부시키가이샤 | 고형 의약제제 |
| EP2167048B1 (fr) * | 2007-05-30 | 2016-10-26 | Wockhardt Limited | Nouvelle forme posologique de comprimé |
| CA2926563A1 (fr) * | 2007-09-27 | 2009-04-02 | Wockhardt Research Centre | Compositions pharmaceutiques de rheine ou de diacereine |
| US20100285114A1 (en) * | 2007-09-27 | 2010-11-11 | Rahul Dabre | Pharmaceutical compositions of rhein or diacerein |
| WO2009048940A2 (fr) * | 2007-10-08 | 2009-04-16 | Dr. Reddy's Laboratories Ltd. | Formulations pharmaceutiques de diacéréine |
| TWI473610B (zh) * | 2008-10-28 | 2015-02-21 | Twi Biotechnology Inc | 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物 |
| KR101190708B1 (ko) * | 2010-03-12 | 2012-10-12 | 주식회사 대웅제약 | 모사프리드 또는 이의 염을 포함하는 서방형 약학 조성물 |
| UA112632C2 (uk) * | 2010-06-16 | 2016-10-10 | Такеда Фармасьютикалз Ю.Ес.Ей., Інк. | Дозована форма з модифікованим вивільненням фебуксостату (варіанти) |
| MX2012015188A (es) * | 2010-06-22 | 2013-05-20 | Twi Pharmaceuticals Inc | Composiciones de liberacion controlada con efecto de alimentos reducido. |
| RU2603050C2 (ru) * | 2011-03-11 | 2016-11-20 | ТиДаблЮАй БАЙОТЕКНОЛОДЖИ, ИНК. | Способы и композиции для лечения гиперурикемии и метаболических нарушений, связанных с гиперурикемией |
-
2015
- 2015-04-20 EP EP15890063.9A patent/EP3285754A4/fr not_active Withdrawn
- 2015-04-20 BR BR112017022509A patent/BR112017022509A2/pt not_active Application Discontinuation
- 2015-04-20 KR KR1020177032849A patent/KR20180013880A/ko unknown
- 2015-04-20 AU AU2015392441A patent/AU2015392441A1/en not_active Abandoned
- 2015-04-20 RU RU2017140079A patent/RU2690372C2/ru active
- 2015-04-20 CN CN201580081063.7A patent/CN107708681A/zh active Pending
- 2015-04-20 MX MX2017013489A patent/MX2017013489A/es unknown
- 2015-04-20 WO PCT/US2015/026678 patent/WO2016171656A1/fr active Application Filing
- 2015-04-20 JP JP2017555702A patent/JP2018513203A/ja active Pending
- 2015-04-20 CA CA2983394A patent/CA2983394A1/fr not_active Abandoned
-
2017
- 2017-10-16 IL IL255073A patent/IL255073A0/en unknown
- 2017-11-17 CO CONC2017/0011722A patent/CO2017011722A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL255073A0 (en) | 2017-12-31 |
| RU2017140079A3 (fr) | 2019-05-20 |
| EP3285754A1 (fr) | 2018-02-28 |
| EP3285754A4 (fr) | 2018-12-19 |
| AU2015392441A1 (en) | 2017-11-09 |
| WO2016171656A1 (fr) | 2016-10-27 |
| CA2983394A1 (fr) | 2016-10-27 |
| BR112017022509A2 (pt) | 2018-07-17 |
| JP2018513203A (ja) | 2018-05-24 |
| RU2690372C2 (ru) | 2019-06-03 |
| CN107708681A (zh) | 2018-02-16 |
| MX2017013489A (es) | 2018-05-22 |
| RU2017140079A (ru) | 2019-05-20 |
| KR20180013880A (ko) | 2018-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017011535A2 (es) | Composiciones de ácido obeticólico y métodos de uso | |
| SV2016005279A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| DOP2016000109A (es) | Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas. | |
| CL2020000946A1 (es) | Métodos y composiciones para la producción de trifosfato de nucleosido y ácido ribonucleico | |
| DK3233130T3 (da) | Nukleinsyrekonstruktioner og genterapivektorer til anvendelse i behandlingen af wilson-sygdom | |
| DK3509638T3 (da) | Præparater med cannabidiolsyreestere og anvendelser deraf | |
| UY37391A (es) | Formulaciones de anticuerpos inhibidores de masp-2 de baja viscosidad y altamente concentradas, kits, y métodos | |
| ECSP14030779A (es) | Inhibidores del nampt | |
| GT201700179A (es) | Formulaciones en polvo nasal para el tratamiento de hipoglicemia | |
| BR112016020181A2 (pt) | Composições de ácido lipoico éster colina e métodos de uso. | |
| CL2019002733A1 (es) | Formulaciones de clorhidrato del ácido 1-amino-1-ciclopropanocarboxílico. | |
| BR112017006851A2 (pt) | uso de ésteres de poliglicerol autoemulsificantes e hidrofóbicos como adjuvantes e agentes antidispersão por aspersão | |
| CL2019002729A1 (es) | Formulaciones de ácido 1-amino-1-ciclopropanocarboxílico. | |
| PH12017501692A1 (en) | Solid forms of menaquinols | |
| CL2019001053A1 (es) | Formulaciones farmacéuticas y métodos para prepararlas. | |
| CL2015001446A1 (es) | Procedimiento de preparación de albumina humana con nivel de oxigeno disuelto reducido. | |
| CL2017000118A1 (es) | Métodos y composiciones para tratar desórdenes relacionados con el vih | |
| SV2018005747A (es) | Composiciones y metodos para estabilizar alfavirus con formulaciones mejoradas | |
| BR112017007753A2 (pt) | uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico. | |
| CL2017000663A1 (es) | Uso de compuestos heterocíclicos fluoroalquenil sulfano para repeler moluscos | |
| CO2017011722A2 (es) | Formulaciones que contienen diacereína y métodos que las utilizan para disminuir el nivel del ácido úrico en sangre | |
| NI201700026A (es) | Compuestos dipeptidil cetoamídicos y su uso para el tratamiento y/o la prevención de la acumulación de grasa. | |
| AR104194A1 (es) | Composición del factor de von willebrand | |
| FR3019002B1 (fr) | Utilisation d'ester(s) d'acide(s) gras comme insecticide. | |
| CL2018000336A1 (es) | Composición para el tratamiento de la mucosidad en las branquias de los peces |